IE00B4Q5ZN47
IE00B4Q5ZN47
Jazz Pharmaceuticals plc
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 14.18B EUR | 15.61B EUR | 11.85B EUR | 10.44B EUR |
Enterprise Value | 16.65B EUR | 18.4B EUR | 15.43B EUR | 14.48B EUR |
Valuation Multiples | ||||
Trailing P/E | 14.97x | 16.6x | 402.32x | -- |
Forward P/E | 8.46x | -- | -- | -- |
Price to Sales | 3.08x | 3.39x | 2.67x | 3.1x |
Price to Book | 2.95x | 3.25x | 2.62x | 2.42x |
EV/Revenue | 3.62x | 4x | 3.48x | 4.3x |
EV/EBITDA | 8.64x | 10.61x | 9.5x | 13.1x |
Price to FCF (P/FCF) | 9.92x | 11.91x | 10.36x | 13.83x |
EV/FCF | 11.65x | 14.04x | 13.49x | 19.17x |
FCF Yield | 10.08% | 8.4% | 9.65% | 7.23% |